In 2002, study researchers stopped giving HT to women with an intact uterus when it
became clear that the risks of taking combined hormones (estrogen plus a progestin)-- higher rates of stroke, breast cancer, heart attack, and blood clots in the lungs and legs — outweighed the benefits, namely, reductions in
osteoporotic fractures and colorectal cancer.